Table I.
Parameters | Group A (≥4 weeks) | Group B (<4 weeks) | P-value |
---|---|---|---|
Cases (N) | 116 | 118 | |
Age (years) | 49.3±8.8 | 47.6±7.8 | 0.098 |
Male/female (N) | 74/42 | 77/41 | 0.514 |
Preoperative anti-TB time (day) | 43±14 (28–56) | 20±6 (14–28) | <0.0001 |
Preoperative VAS | 6.6±1.8 | 6.4±1.7 | 0.379 |
Preoperative Cobb angle (°) | 32.9±5.2 | 34.1±4.8 | 0.0655 |
ESR (mm/h) | 42.9±1.2 | 54.1±1.5 | 0.001 |
CRP (mg/l) | 20.24±3.68 | 26.78±3.56 | 0.001 |
TB involved vertebra segment | |||
T1 | 1 | 3 | |
T2–3 | 12 | 10 | |
T4–6 | 4 | 6 | |
T5–8 | 16 | 14 | |
T9 | 20 | 22 | |
T10–12 | 59 | 67 | |
Combined disease | |||
Disseminated pulmonary tuberculosis | 3 | 1 | |
Secondary hypertension | 3 | 5 | |
Hypoproteinemia | 4 | 3 | |
Type II diabetes | 2 | 3 | |
Coronary heart disease | 4 | 1 | |
Old myocardial infarction | 1 | 1 | |
Cardiac insufficiency | 0 | 2 | |
Sinus tract | 1 | 1 | |
Abnormal liver function | 0 | 2 | |
Drug eruption | 2 | 0 |
ESR, erythrocyte sedimentation rate; CRP, C-reactive protein; TB, tuberculosis; VAS, visual analogue scale.